Raymond James Financial Services Advisors’s Carisma Therapeutics CARM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-1,050
Closed -$12.8K 3258
2022
Q4
$12.8K Sell
1,050
-37
-3% -$451 ﹤0.01% 3161
2022
Q3
$9K Buy
+1,087
New +$9K ﹤0.01% 3184
2021
Q4
Sell
-1,133
Closed -$18K 3251
2021
Q3
$18K Sell
1,133
-12
-1% -$191 ﹤0.01% 3214
2021
Q2
$106K Buy
1,145
+88
+8% +$8.15K ﹤0.01% 3120
2021
Q1
$55K Buy
1,057
+152
+17% +$7.91K ﹤0.01% 3080
2020
Q4
$24K Hold
905
﹤0.01% 2922
2020
Q3
$25K Buy
+905
New +$25K ﹤0.01% 2786